SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: harkenman who wrote (80)3/31/1997 1:42:00 AM
From: E. Graphs   of 998
 
Technically, in Jan/97 CEPH broke a very long downtrend from early Jan/96 when it was trading at $40. Relative strength is now at 55. Volume follows price. First support is now at 20 3/4, which also happens to be the 200day MA; second support is at 18. A break below 18 would NOT be good for this chart. (Because of all the positives I don't expect this to happen.) First resistance is at 24 and also happens to be the 50day), second resistance at 26, and a close above 27 1/2 indicates to me a price target of 37.
Very positive that CEPH closed up on 3/27, because R/S needs to improve now. The Daily Graphs show 12% debt, 3.93x bk, and short interest at -14%. EPS estimate for 97 is -2.50 and +.37 for 98, which would be the first profit that I see going back to 1991 (my source's limit). Interesting stock.
When I checked sentiment (about MYOTROPHIN) over on the Chiron thread I couldn't help but notice rumors of a J&J merger over there. Such things make me glad that I chart.

All info above IMHO of course.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext